WO2014016819A1 - Device and method for the application of a curable fluid composition to a bodily organ - Google Patents
Device and method for the application of a curable fluid composition to a bodily organ Download PDFInfo
- Publication number
- WO2014016819A1 WO2014016819A1 PCT/IL2013/000060 IL2013000060W WO2014016819A1 WO 2014016819 A1 WO2014016819 A1 WO 2014016819A1 IL 2013000060 W IL2013000060 W IL 2013000060W WO 2014016819 A1 WO2014016819 A1 WO 2014016819A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organ
- bodily organ
- length dimension
- flexible material
- piece
- Prior art date
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 170
- 239000012530 fluid Substances 0.000 title claims abstract description 93
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims description 54
- 239000000463 material Substances 0.000 claims abstract description 74
- 238000004891 communication Methods 0.000 claims abstract description 5
- 108010049003 Fibrinogen Proteins 0.000 claims description 40
- 102000008946 Fibrinogen Human genes 0.000 claims description 40
- 229940012952 fibrinogen Drugs 0.000 claims description 40
- 108090000190 Thrombin Proteins 0.000 claims description 35
- 229960004072 thrombin Drugs 0.000 claims description 35
- 108010073385 Fibrin Proteins 0.000 claims description 13
- 102000009123 Fibrin Human genes 0.000 claims description 13
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 13
- 229950003499 fibrin Drugs 0.000 claims description 13
- 210000002249 digestive system Anatomy 0.000 claims description 11
- 210000002429 large intestine Anatomy 0.000 claims description 7
- 210000000813 small intestine Anatomy 0.000 claims description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 6
- 210000003238 esophagus Anatomy 0.000 claims description 6
- 210000003405 ileum Anatomy 0.000 claims description 6
- 210000002784 stomach Anatomy 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 210000001072 colon Anatomy 0.000 claims description 4
- 210000001187 pylorus Anatomy 0.000 claims description 4
- 241001269524 Dura Species 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 210000000436 anus Anatomy 0.000 claims description 3
- 210000004534 cecum Anatomy 0.000 claims description 3
- 210000001198 duodenum Anatomy 0.000 claims description 3
- 229920001973 fluoroelastomer Polymers 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 210000001630 jejunum Anatomy 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 229920001084 poly(chloroprene) Polymers 0.000 claims description 3
- 210000000664 rectum Anatomy 0.000 claims description 3
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 230000002485 urinary effect Effects 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 239000000306 component Substances 0.000 description 78
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 50
- -1 flbronectin Proteins 0.000 description 29
- 238000005507 spraying Methods 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 239000000565 sealant Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 11
- 238000007789 sealing Methods 0.000 description 11
- 239000007921 spray Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 210000002381 plasma Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 230000003872 anastomosis Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 108010071289 Factor XIII Proteins 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 229940012444 factor xiii Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108010047303 von Willebrand Factor Proteins 0.000 description 4
- 102100036537 von Willebrand factor Human genes 0.000 description 4
- 229960001134 von willebrand factor Drugs 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 102000013566 Plasminogen Human genes 0.000 description 3
- 108010051456 Plasminogen Proteins 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229960003589 arginine hydrochloride Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002324 minimally invasive surgery Methods 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 3
- 229960000401 tranexamic acid Drugs 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 108010054218 Factor VIII Proteins 0.000 description 2
- 102000001690 Factor VIII Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 102100035140 Vitronectin Human genes 0.000 description 2
- 108010031318 Vitronectin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 229960000301 factor viii Drugs 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002357 laparoscopic surgery Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940012957 plasmin Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000504 antifibrinolytic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920005583 poly(anhydride-co-imide) Polymers 0.000 description 1
- 229920001982 poly(ester urethane) Polymers 0.000 description 1
- 229920001691 poly(ether urethane) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229940065514 poly(lactide) Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000002694 regional anesthesia Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229960003766 thrombin (human) Drugs 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B17/1114—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of the digestive tract, e.g. bowels or oesophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
- A61B2017/00495—Surgical glue applicators for two-component glue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00884—Material properties enhancing wound closure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015523654A JP6275712B2 (en) | 2012-07-24 | 2013-07-21 | Apparatus and method for application of a curable fluid composition to a body organ |
EP13750943.6A EP2877101A1 (en) | 2012-07-24 | 2013-07-21 | Device and method for the application of a curable fluid composition to a bodily organ |
CA2879933A CA2879933A1 (en) | 2012-07-24 | 2013-07-21 | Device and method for the application of a curable fluid composition to a bodily organ |
CN201380039333.9A CN104470445B (en) | 2012-07-24 | 2013-07-21 | Device and method for curable fluid composition to be applied to organ |
AU2013294557A AU2013294557B2 (en) | 2012-07-24 | 2013-07-21 | Device and method for the application of a curable fluid composition to a bodily organ |
IL236821A IL236821B (en) | 2012-07-24 | 2015-01-20 | Device and method for the application of a curable fluid composition to a bodily organ |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261675206P | 2012-07-24 | 2012-07-24 | |
US61/675,206 | 2012-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014016819A1 true WO2014016819A1 (en) | 2014-01-30 |
Family
ID=49003946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2013/000060 WO2014016819A1 (en) | 2012-07-24 | 2013-07-21 | Device and method for the application of a curable fluid composition to a bodily organ |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2877101A1 (en) |
JP (1) | JP6275712B2 (en) |
CN (1) | CN104470445B (en) |
AU (1) | AU2013294557B2 (en) |
CA (1) | CA2879933A1 (en) |
IL (1) | IL236821B (en) |
WO (1) | WO2014016819A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2954856A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
EP2954858A2 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for reinforcing a staple line |
EP2954857A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Adjunct materials and methods of using same in surgical methods for tissue sealing |
EP2954850A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing stapled tissue |
EP2954855A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Woven and fibrous materials for reinforcing a staple line |
US9700311B2 (en) | 2013-11-08 | 2017-07-11 | Ethicon Llc | Tissue ingrowth materials and method of using the same |
US9826965B2 (en) | 2014-06-10 | 2017-11-28 | Ethicon Llc | Devices for sealing a body lumen |
US9936950B2 (en) | 2013-11-08 | 2018-04-10 | Ethicon Llc | Hybrid adjunct materials for use in surgical stapling |
US10206686B2 (en) | 2014-06-10 | 2019-02-19 | Ethicon Llc | Bronchus sealants and methods of sealing bronchial tubes |
US10456129B2 (en) | 2013-11-08 | 2019-10-29 | Ethicon Llc | Positively charged implantable materials and method of forming the same |
US11446027B2 (en) | 2020-11-25 | 2022-09-20 | Cilag Gmbh International | Compressible knitted adjuncts with surface features |
US11512415B2 (en) | 2018-02-21 | 2022-11-29 | Cilag Gmbh International | Knitted tissue scaffolds |
US11648007B2 (en) | 2020-11-25 | 2023-05-16 | Cilag Gmbh International | Compressible knitted adjuncts with varying fiber features |
US11678883B2 (en) | 2020-11-25 | 2023-06-20 | Cilag Gmbh International | Compressible knitted adjuncts with varying interconnections |
US11690617B2 (en) | 2020-11-25 | 2023-07-04 | Cilag Gmbh International | Compressible knitted adjuncts with finished edges |
US11707279B2 (en) | 2020-11-25 | 2023-07-25 | Cilag Gmbh International | Compressible knitted adjuncts with finished edges |
US11708652B2 (en) | 2018-02-21 | 2023-07-25 | Cilag Gmbh International | Knitted tissue scaffolds |
USD1013171S1 (en) | 2018-02-21 | 2024-01-30 | Cilag Gmbh International | Knitted tissue scaffold |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080114385A1 (en) * | 2006-11-10 | 2008-05-15 | Byrum Randal T | Method and Device for Effecting Anastomosis of Hollow Organ Structures Using Adhesive and Fasteners |
EP2186485A1 (en) * | 2008-11-13 | 2010-05-19 | Tyco Healthcare Group, LP | Super elastic loop extraluminal materials delivery instrument |
US20120116300A1 (en) * | 2009-02-20 | 2012-05-10 | Banks Jr Samuel D | Activation and delivery devices for therapeutic compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5749895A (en) * | 1991-02-13 | 1998-05-12 | Fusion Medical Technologies, Inc. | Method for bonding or fusion of biological tissue and material |
EP1253857B1 (en) * | 2000-02-03 | 2009-01-21 | Tissuemed Limited | Device for the closure of a surgical puncture |
CN101043843A (en) * | 2004-06-30 | 2007-09-26 | 詹姆士·V·西茨曼 | Medical devices for minimally invasive surgeries and other internal procedures |
AU2005295476B2 (en) * | 2004-10-18 | 2011-03-24 | Covidien Lp | Extraluminal sealant applicator and method |
US20070123877A1 (en) * | 2005-11-15 | 2007-05-31 | Aoi Medical, Inc. | Inflatable Device for Restoring Anatomy of Fractured Bone |
US8500776B2 (en) * | 2010-02-08 | 2013-08-06 | Covidien Lp | Vacuum patch for rapid wound closure |
-
2013
- 2013-07-21 CA CA2879933A patent/CA2879933A1/en not_active Abandoned
- 2013-07-21 AU AU2013294557A patent/AU2013294557B2/en not_active Ceased
- 2013-07-21 EP EP13750943.6A patent/EP2877101A1/en not_active Withdrawn
- 2013-07-21 CN CN201380039333.9A patent/CN104470445B/en active Active
- 2013-07-21 WO PCT/IL2013/000060 patent/WO2014016819A1/en active Application Filing
- 2013-07-21 JP JP2015523654A patent/JP6275712B2/en not_active Expired - Fee Related
-
2015
- 2015-01-20 IL IL236821A patent/IL236821B/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080114385A1 (en) * | 2006-11-10 | 2008-05-15 | Byrum Randal T | Method and Device for Effecting Anastomosis of Hollow Organ Structures Using Adhesive and Fasteners |
EP2186485A1 (en) * | 2008-11-13 | 2010-05-19 | Tyco Healthcare Group, LP | Super elastic loop extraluminal materials delivery instrument |
US20120116300A1 (en) * | 2009-02-20 | 2012-05-10 | Banks Jr Samuel D | Activation and delivery devices for therapeutic compositions |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9700311B2 (en) | 2013-11-08 | 2017-07-11 | Ethicon Llc | Tissue ingrowth materials and method of using the same |
US11937809B2 (en) | 2013-11-08 | 2024-03-26 | Cilag Gmbh International | Tissue ingrowth materials and method of using the same |
US11812953B2 (en) | 2013-11-08 | 2023-11-14 | Cilag Gmbh International | Tissue ingrowth materials and method of using the same |
US11564680B2 (en) | 2013-11-08 | 2023-01-31 | Cilag Gmbh International | Tissue ingrowth materials and method of using the same |
US11219451B2 (en) | 2013-11-08 | 2022-01-11 | Cilag Gmbh International | Tissue ingrowth materials and method of using the same |
US10456129B2 (en) | 2013-11-08 | 2019-10-29 | Ethicon Llc | Positively charged implantable materials and method of forming the same |
US10285691B2 (en) | 2013-11-08 | 2019-05-14 | Ethicon Llc | Tissue ingrowth materials and method of using the same |
US9936950B2 (en) | 2013-11-08 | 2018-04-10 | Ethicon Llc | Hybrid adjunct materials for use in surgical stapling |
US9936954B2 (en) | 2014-06-10 | 2018-04-10 | Ethicon Llc | Devices and methods for sealing staples in tissue |
US10390828B2 (en) | 2014-06-10 | 2019-08-27 | Ethicon Llc | Devices and methods for sealing staples in tissue |
WO2015191219A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
WO2015191277A2 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Adjunct materials and methods of using same in surgical methods for tissue sealing |
WO2015191218A2 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Devices and methods for sealing staples in tissue |
WO2015191258A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for reinforcing a staple line |
WO2015191279A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for sealing stapled tissue |
WO2015191187A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
WO2015191217A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Devices and methods for sealing staples in tissue |
WO2015191229A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Woven and fibrous materials for reinforcing a staple line |
EP2954855A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Woven and fibrous materials for reinforcing a staple line |
US9801630B2 (en) | 2014-06-10 | 2017-10-31 | Ethicon Llc | Methods and devices for reinforcing a staple line |
US9826965B2 (en) | 2014-06-10 | 2017-11-28 | Ethicon Llc | Devices for sealing a body lumen |
US9848871B2 (en) | 2014-06-10 | 2017-12-26 | Ethicon Llc | Woven and fibrous materials for reinforcing a staple line |
US9913646B2 (en) | 2014-06-10 | 2018-03-13 | Ethicon Llc | Devices for sealing staples in tissue |
US9924946B2 (en) | 2014-06-10 | 2018-03-27 | Ethicon Llc | Devices and methods for sealing staples in tissue |
EP2954856A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
EP2954848A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
US10172611B2 (en) | 2014-06-10 | 2019-01-08 | Ethicon Llc | Adjunct materials and methods of using same in surgical methods for tissue sealing |
US10206686B2 (en) | 2014-06-10 | 2019-02-19 | Ethicon Llc | Bronchus sealants and methods of sealing bronchial tubes |
EP2954852A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
WO2015191228A1 (en) | 2014-06-10 | 2015-12-17 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
EP2954850A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing stapled tissue |
US10610226B2 (en) | 2014-06-10 | 2020-04-07 | Ethicon Endo-Surgery, Inc. | Methods and devices for sealing stapled tissue |
US10966722B2 (en) | 2014-06-10 | 2021-04-06 | Ethicon Llc | Adjunct materials and methods of using same in surgical methods for tissue sealing |
EP3881775A2 (en) | 2014-06-10 | 2021-09-22 | Ethicon Endo-Surgery, Inc. | Adjunct materials for tissue sealing |
EP2954857A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Adjunct materials and methods of using same in surgical methods for tissue sealing |
EP2954858A2 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for reinforcing a staple line |
US11911034B2 (en) | 2014-06-10 | 2024-02-27 | Cilag Gmbh International | Adjunct materials and methods of using same in surgical methods for tissue sealing |
EP2954853A1 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
US11596402B2 (en) | 2014-06-10 | 2023-03-07 | Cilag Gmbh International | Adjunct materials and methods of using same in surgical methods for tissue sealing |
US11607221B2 (en) | 2014-06-10 | 2023-03-21 | Cilag Gmbh International | Adjunct materials and methods of using same in surgical methods for tissue sealing |
EP2954851A2 (en) | 2014-06-10 | 2015-12-16 | Ethicon Endo-Surgery, Inc. | Devices for sealing staples in tissue |
US11708652B2 (en) | 2018-02-21 | 2023-07-25 | Cilag Gmbh International | Knitted tissue scaffolds |
USD1013171S1 (en) | 2018-02-21 | 2024-01-30 | Cilag Gmbh International | Knitted tissue scaffold |
US11512415B2 (en) | 2018-02-21 | 2022-11-29 | Cilag Gmbh International | Knitted tissue scaffolds |
US11678883B2 (en) | 2020-11-25 | 2023-06-20 | Cilag Gmbh International | Compressible knitted adjuncts with varying interconnections |
US11690617B2 (en) | 2020-11-25 | 2023-07-04 | Cilag Gmbh International | Compressible knitted adjuncts with finished edges |
US11707279B2 (en) | 2020-11-25 | 2023-07-25 | Cilag Gmbh International | Compressible knitted adjuncts with finished edges |
US11648007B2 (en) | 2020-11-25 | 2023-05-16 | Cilag Gmbh International | Compressible knitted adjuncts with varying fiber features |
US11446027B2 (en) | 2020-11-25 | 2022-09-20 | Cilag Gmbh International | Compressible knitted adjuncts with surface features |
Also Published As
Publication number | Publication date |
---|---|
CN104470445B (en) | 2019-08-06 |
IL236821B (en) | 2020-01-30 |
AU2013294557B2 (en) | 2017-05-25 |
AU2013294557A1 (en) | 2015-03-05 |
CN104470445A (en) | 2015-03-25 |
EP2877101A1 (en) | 2015-06-03 |
CA2879933A1 (en) | 2014-01-30 |
IL236821A0 (en) | 2015-03-31 |
JP6275712B2 (en) | 2018-02-07 |
JP2015525641A (en) | 2015-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013294557B2 (en) | Device and method for the application of a curable fluid composition to a bodily organ | |
US20210315557A1 (en) | Device and Method for the Application of a Curable Fluid Composition to a Bodily Organ | |
US11564671B2 (en) | Device and method for the application of a curable fluid composition to a portion of a bodily organ | |
US8216259B2 (en) | Compositions and methods for joining non-conjoined lumens | |
US20110208238A1 (en) | Applicator delivery tip extension | |
WO2009153748A9 (en) | Methods and devices for use with sealants | |
US20080262519A1 (en) | Compositions and methods for joining non-conjoined lumens | |
US20210038210A1 (en) | Applicator For Depositing A Layer Of Adhesive Or Sealant Composition On A Biological And/Or Prosthetic Tissue | |
US20130039899A1 (en) | Methods and devices for applying tissue sealants and adhesives | |
CN117915962A (en) | Anti-dissolution tissue adhesive dressing application and delivery thereof | |
JP2017524482A (en) | Medical device for repairing soft tissue and method of using the medical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13750943 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 236821 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2879933 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2015523654 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013750943 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2013294557 Country of ref document: AU Date of ref document: 20130721 Kind code of ref document: A |